Aprogen Medicines Inc. (KRX:007460)
South Korea · Delayed Price · Currency is KRW 656.00
+1.00 (0.15%)
At close: Jul 18, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
Medicine | 60.12B | Log In | Log In | Log In | Log In | Upgrade |
Medicine Growth | -4.51% | Log In | Log In | Log In | Log In | Upgrade |
Steel | 46.29B | Log In | Log In | Log In | Log In | Upgrade |
Steel Growth | 0.62% | Log In | Log In | Log In | Log In | Upgrade |
Hardfacing | 32.69B | Log In | Log In | Log In | Log In | Upgrade |
Hardfacing Growth | 8.80% | Log In | Log In | Log In | Log In | Upgrade |
NUKON | 8.46B | Log In | Log In | Log In | Log In | Upgrade |
NUKON Growth | 120.68% | Log In | Log In | Log In | Log In | Upgrade |
Biosimilar | 551.41M | Log In | Log In | Log In | Log In | Upgrade |
Biosimilar Growth | -85.46% | Log In | Log In | Log In | Log In | Upgrade |
Game | 39.49M | Log In | Log In | Log In | Log In | Upgrade |
Game Growth | -88.96% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.97B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -45.16% | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Construction - NUKON | - | Log In | Log In | Log In | Log In | Upgrade |
Construction - NUKON Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Glycholine soft capsule | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Glycholine soft capsule Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Foam Glass | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Foam Glass Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Glutanex Injection | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - Glutanex Injection Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Service - Dragon Raja Origin | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
South Korea | 139.72B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | 6.15% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 10.39B | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | -45.18% | Log In | Log In | Log In | Log In | Upgrade |